Literature DB >> 25094035

Oxytocin has therapeutic effects on cancer, a hypothesis.

Mohammad Hossein Imanieh1, Fereshte Bagheri1, Ali Mohammad Alizadeh2, Soheil Ashkani-Esfahani1.   

Abstract

Oxytocin (OT) is the first peptide hormone structurally assessed and chemically synthesized in biologically active form. This hormone acts as an important factor in a human reproductive system particularly during pregnancy and lactation in women. So far, different therapeutic roles for OT have been identified as a spectrum from central and peripheral actions on male and female reproductive systems, circulatory system, musculoskeletal system, etc. Some in vitro and in vivo studies also revealed that OT is responsible for bivariate biological functions involved in cancer as following. By activating OT receptor in tumoral cells, OT enacts as a growth regulator, whether activator or inhibitor. Regarding the increase of OT in some conditions such as breastfeeding, exercise, and multiparity, we can relate the effect of these conditions on cancer with OT effects. Based on this hypothesis, we present a review on the effects of this neuropeptide on various types of cancer and also the influence of these conditions on the same cancer.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Neuropeptide; Oxytocin; Review

Mesh:

Substances:

Year:  2014        PMID: 25094035     DOI: 10.1016/j.ejphar.2014.07.053

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

Review 1.  Mitochondrial targeted peptides for cancer therapy.

Authors:  Sadaf Farsinejad; Zohre Gheisary; Sanaz Ebrahimi Samani; Ali Mohammad Alizadeh
Journal:  Tumour Biol       Date:  2015-07-05

2.  Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer.

Authors:  Trisheena Harricharran; Olorunseun O Ogunwobi
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2019-12-14

3.  Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer.

Authors:  Jianchao Ying; Teng Xu; Qian Wang; Jun Ye; Jianxin Lyu
Journal:  Epigenetics       Date:  2018-07-30       Impact factor: 4.528

4.  Oxytocin receptor genetic alterations in hepatocellular carcinoma.

Authors:  Trisheena Harricharran; Olorunseun O Ogunwobi
Journal:  SN Compr Clin Med       Date:  2019-06-14

5.  Identification of oxytocin-related lncRNAs and assessment of their expression in breast cancer.

Authors:  Sepehr Behtaji; Soudeh Ghafouri-Fard; Arezou Sayad; Ali Sattari; Mathieu Rederstorff; Mohammad Taheri
Journal:  Sci Rep       Date:  2021-03-19       Impact factor: 4.379

6.  Pregnancy-Associated Risk Factors of Postpartum Breast Cancer in Korea: A Nationwide Health Insurance Database Study.

Authors:  Eun Joo Kang; Jae Hong Seo; Log Young Kim; Geun U Park; Min-Jeong Oh; Pyoung-Jae Park; Geum Joon Cho
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

7.  The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer.

Authors:  Huan Xu; Shi Fu; Qi Chen; Meng Gu; Juan Zhou; Chong Liu; Yanbo Chen; Zhong Wang
Journal:  Oncotarget       Date:  2017-05-09

8.  Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.

Authors:  Jianchao Ying; Qian Wang; Teng Xu; Jianxin Lyu
Journal:  Cancer Med       Date:  2018-04-17       Impact factor: 4.452

9.  Low fertility may be a significant determinant of ovarian cancer worldwide: an ecological analysis of cross- sectional data from 182 countries.

Authors:  Wenpeng You; Ian Symonds; Maciej Henneberg
Journal:  J Ovarian Res       Date:  2018-08-16       Impact factor: 4.234

10.  Greater family size is associated with less cancer risk: an ecological analysis of 178 countries.

Authors:  Wenpeng You; Frank J Rühli; Renata J Henneberg; Maciej Henneberg
Journal:  BMC Cancer       Date:  2018-09-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.